Abstract
The mechanisms of intestinal absorption have not been clearly elucidated for cadmium, a toxic metal. In this work, we show the implication of distinct proteins in cadmium transport, and the transport step where these proteins are involved. We first validated the HT-29 model by evaluating nontoxic doses of cadmium (ranging from 1 to 20 μmol/L), and by quantifying metal uptake and transepithelial transport. The time-course of 1 μmol/L cadmium uptake at pH 7.5 showed three steps: a rapid one during the first 4 min, probably due to cadmium binding to the membrane; a slower one, characterized by K m of 1.65±0.54 μmol/L and V max of 3.9±0.3 pmol/min per mg protein; and a third, corresponding to slow accumulation that was not equilibrated even after 48 h of cadmium exposure. Intracellular metallothionein content following 1 or 5 μmol/L cadmium exposure showed a significant increase after 6 h of exposure, and was not equilibrated even after 72 h, allowing cadmium accumulation. After 24 h of exposure, metallothionein content was 5-fold, 14-fold, 26-fold, and 50-fold, respectively, for cells grown in the presence of 1, 5, 10, and 20 μmol/L cadmium, compared to control cells. The second step of uptake, characterized by carrier-mediated transport, was markedly increased at pH 5.5, compared to pH 7.5, and strongly inhibited by the metabolic inhibitor dinitrophenol. Moreover Nramp2 transporter cDNA was present in HT-29 cells. These data suggest the involvement of a proton-coupled transporter, which may be the divalent cation transporter Nramp2 (natural resistance-associated macrophage protein 2). Cadmium uptake was also inhibited by copper, zinc, and para-chloromercuribenzenesulfonate (pCMBS), but not by verapamil or ouabain. Taken together, our results indicate that cadmium could enter HT-29 cell by Nramp2 proton-coupled active transport and by diffusion, and accumulates in the cell as long as it binds to metallothionein. Cadmium toxicity could depend partly on the activity of Nramp2, and partly on metallothionein content.
Similar content being viewed by others
References
Andersen O, Nielsen JB, Sorensen JA, Scherrebeck L. Experi-mental localization of intestinal uptake sites for metals (Cd, Hg, Zn, Se) in vivo in mice. Environ Health Perspect. 1994;102:199-206.
Bhattacharyya MH, Wilson AK, Silbergeld EK, Watson L, Jeffery E. Metal-induced osteotoxicities. In: Goyer RA, Klaassen CD, Waalkes MP, eds. Metal toxicology. San Diego: Academic Press; 1995:465-510.
Blais A, Aymard P, Lacour B. Paracellular calcium transport across Caco-2 and HT29 cell monolayers. Eur J Physiol. 1997;434:300-5.
Blais A, Lecoeur S, Milhaud G, Tomé D, Kolf-Clauw M. Cadmium uptake and transepithelial transport in control and long-term exposed Caco-2 cells: the role of metallothio-nein. Toxicol Appl Pharmacol. 1999;160:76-85.
Bobilya DJ, Briske Anderson M, Reeves PG. Zinc transport into endothelial cells is a facilitated process. J Cell Physiol. 1992;151:1-7.
Danielson KG, Ohi S, Huang PC. Immunochemical detection of metallothionein in specific epithelial cells or rat organs. Proc Natl Acad Sci USA. 1982;79:2301-4.
Dressman JB, Berardi RR, Dermentzoglou LC, et al. Upper gastrointestinal pH in young, healthy men and women. Pharm Res. 1990;7:756-61.
Duizer E, Gilde AJ, Versantvoort CHM, Groten JP. Effects of cadmium chloride on the paracellular barrier function of intestinal cell lines. Toxicol Appl Pharmacol. 1999;155:117-26.
Elisma F, Jumarie C. Evidence for cadmium uptake through Nramp2: metal speciation studies with Caco-2 cells. Bio-chem Biophys Res Commun. 2001;285:662-8.
Elsenhans B, Kolb K, Schymann K, Forth W. The longitudinal distribution of cadmium, zinc, copper, iron, and metal-lothionein in the small-intestinal mucosa of rats after administration of cadmium chloride. Biol Trace Elem Res. 1994;41:31-46.
Elsenhans B, Strugala GJ, Schäfer SG. Small-intestinal absorp-tion of cadmium and the significance of mucosal metal-lothionein. Hum Exp Toxicol. 1997;16:429-34.
Endo T, Kimura O, Sakata M. Effects of zinc and copper on uptake of cadmium by LLC-PK1 cells. Biol Pharm Bull. 1996;19:944-8.
Endo T. Transport of cadmium across the apical membrane of epithelial cell lines. Comp Biochem Physiol C Toxicol Pharmacol. 2002;131:223-9.
Evans DF, Pye G, Bramley R, Clark AG, Dyson TJ, Hardcastle JD. Measurements of gastrointestinal pH profiles in normal ambulant human subjects. Gut. 1988;29:1035-41.
Fogh J, Fogh JM, Orfeo T. One hundred and twenty seven cultured human tumor cell lines producing tumors in nude mice. J Natl Canc Inst. 1977;59:221-6.
Foulkes EC. On the mechanism of transfer of heavy metals across cell membranes. Toxicology. 1988;52:263-72.
Foulkes EC. Further findings on the mechanism of cadmium uptake by intestinal mucosal cells (step 1 of Cd absorption). Toxicology. 1991;70:261-70.
Foulkes EC, Bergman D. Inorganic mercury absorption in mature and immature rat jejunum: transcellular and inter-cellular pathways in vivo and everted sacs. Toxicol Appl Pharmacol. 1993;120:89-95.
Foulkes EC, MacMullen DM. Kinetics of trans-epithelial movement of heavy metals in rat jejunum. Am J Physiol. 1987;253:134-8.
Friberg L, Kjellström T, Nordberg GF. Cadmium. In: Friberg L, Nordberg GF, Vouk VB, eds. Handbook on the toxicol-ogy of metals. Amsterdam: Elsevier; 1986:II:130-75.
Goering PL, Waalkes MP, Klaassen CD. Toxicology of cad-mium. In: Goyer RA, Cherian MG, eds. Toxicology of metals: biochemical aspects. Handbook of experimental pharmacology. New York: Springer-Verlag; 1995:115:189-213.
Goon D, Klaassen CD. Dosage-dependent absorption of cadmium in the rat intestine measured in situ. Toxicol Appl Pharmacol. 1989;100:41-50.
Gunshin H, Mackenzie B, Berger UV, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 1997;388: 482-8.
Han O, Fleet JC, Wood RJ. Reciprocal regulation of HFE and Nramp2 gene expression by iron in human intestinal cells. J Nutr. 1999;129:98-104.
Jarup L, Berglund M, Elinder CG, Nordberg G, Vahter M. Health effects of cadmium exposure: a review of literature and a risk estimate. Scand J Work Environ Health. 1998; 24:1-51.
Jin N, Kimura M, Yokoi K, Itokawa Y. A gel filtration high-performance liquid chromatographic method for determi-nation of hepatic and renal metallothionein of rat and in comparison with the cadmium-saturation method. Biol Trace Elem Res. 1993;36:183-90.
Jumarie C, Campbell PGC, Berteloot A, Houde M, Denizeau F. Caco-2 cell line used as an in vitro model to study cadmium accumulation in intestinal epithelial cells. J Membr Biol. 1997;158:31-48.
Jumarie C, Campbell PGC, Houde M, Denizeau F. Evidence for an intracellular barrier to cadmium transport through Caco-2 cell monolayers. J Cell Physiol. 1999;180:285-97.
Klaassen CD, Liu J. Role of metallothionein in cadmium-induced hepatotoxicity and nephrotoxicity. Drug Metab Rev. 1997;29:79-102.
Klaassen CD, Liu J, Choudhuri S. Metallothionein: an intra-cellular protein to protect against cadmium toxicity. Annu Rev Pharmacol Toxicol. 1999;39:267-94.
Lind Y, Wicklund Glynn A. The involvement of metallothio-nein in the intestinal absorption of cadmium in mice. Toxicol Lett. 1997;91:179-87.
Min KS, Fujita Y, Onosaka S, Tanaka K. Role of intestinal metallothionein in absorption and distribution of orally administered cadmium. Toxicol Appl Pharmacol. 1991;109: 7-16.
Min KS, Nakatsubo T, Kawamura S, Fujita Y, Onosaka S, Tanaka K. Effects of mucosal metallothionein in small intestine on tissue distribution of cadmium after oral administration of cadmium compounds. Toxicol Appl Phar-macol. 1992;113:306-10.
Mitchell DB, Santone KS, Acosta D. Evaluation of cytotoxicity in cultured cells by enzyme leakage. J Tissue Cult Methods. 1980;6:113-17.
Morselt AF. Environmental pollutants and diseases. A cell biological approach using chronic cadmium exposure in the animal model as a paradigm case. Toxicology. 1991;70: 1-132.
Niewenhuis RJ, Dimitriu C, Prozialeck WC. Ultrastructural characterization of the early changes in intercellular junc-tions in response to cadmium (Cd2+) exposure in LLC-PK1 cells. Toxicol Appl Pharmacol. 1997;142:1-12.
Ohta H, Cherian MG. Gastrointestinal absorption of cadmium and metallothionein. Toxicol Appl Pharmacol. 1991;107: 63-72.
Phillpotts CJ. The autoradiographic localisation of retained orally administrated tracer within Paneth cells of rat duo-denum. Toxicology. 1984;33:59-66.
Pigman EA, Blanchard J, Laird HE. A study of cadmium transport pathways using the Caco-2 cell model. Toxicol Appl Pharmacol. 1997;142:243-7.
Pinot F, Kreps SE, Bachelet M, Hainaut P, Bakonyi M, Polla BS. Cadmium in the environnement: sources, mechanisms of biotoxicity, and biomarkers. Rev Environ Health. 2000; 15:299-323.
Rindley MJ, Traber MG. A specific sorting signal is not required for the polarized secretion of newly synthesized proteins from cultured intestinal cells. J Cell Biol. 1988; 107:471-9.
Satarug S, Haswell-Elkins MR, Moore MR. Safe levels of cadmium intake to prevent renal toxicity in human subjects. Br J Nutr. 2000;84:791-802.
Saito S, Kojima Y. Differential role of metallothionein on Zn, Cd and Cu accumulation in hepatic cytosol of rats. CellMol Life Sci. 1997;53:267-70.
Scarino ML, Poverini R, Di Lullo G, Bises G. Metallothionein gene expression in the intestinal cell: modulation of mRNA and protein synthesis by copper and zinc. Biochem Soc Trans. 1991;19:283s-91s.
Slotki IN, Breuer WV, Greger R, Cabantchik ZI. Long-term cAMP activation of Na+-K+-2Cl--cotransporter activity in HT-29 human adenocarcinoma cells. J Am Physiol Soc. 1993;82:857-65.
Sorensen JA, Nielsen JB, Andersen O. Identification of the gastrointestinal absorption site for cadmium chloride in vivo. Pharmacol Toxicol. 1993;73:169-73.
Tandy S, Williams M, Leggett A, et al. Nramp2 expression is associated with pH-dependent iron uptake across the apical membrane of human intestinal Caco-2 cells. J Biol Chem. 2000;275:1023-9.
Thévenod F, Friedmann JM, Katsen AD, Hauser IA. Up-regulation of multidrug resistance P-glycoprotein via nucle-ar factor-kB activation protects kidney proximal tubule cells from cadmium-and reactive oxygen species-induced apop-tosis. J Biol Chem. 2000;275:1887-96.
Turner JT, Franklin CC, Bollinger DW, Kim HD. Vasoactive intestinal peptide stimulates active K+ transport and Na+K+Cl--cotransport in HT-29 cells. J Biol Chem. 1989; 264:6667-74.
Velcich A, Palumbo L, Jarry A, Laboisse C, Racevskis J, Augenlicht L. Patterns of expression of lineage-specific markers during the in vitro-induced differentiation of HT29 colon carcinoma cells. Cell Growth Differ. 1995;6:749-57.
Viallard V, Denis C, Trocheris V, Murat JC. Effect of glutamine deprivation and glutamate or ammonium chloride addition on growth rate, metabolism and differentiation of human colon cancer cell-line HT29. Int J Biochem. 1986;18:263-9.
Waalkes MP, Misra RR. Cadmium carcinogenicity and geno-toxicity. In: Chang L, ed. Toxicology of metals. Boca Raton, FL: CRC Press; 1996:231-44.
Webb M. The chemistry, biochemistry and biology of cadmium: Amsterdam: Elsevier; 1979.
Zoller H, Pietrangelo A, Vogel W, Weiss G. Duodenal metal-transporter (DMT-1, NRAMP-2) expression in patients with hereditary haemochromatosis. Lancet. 1999;353: 2120-3.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lecoeur, S., Huynh-Delerme, C., Blais, A. et al. Implication of distinct proteins in cadmium uptake and transport by intestinal cells HT-29. Cell Biol Toxicol 18, 409–423 (2002). https://doi.org/10.1023/A:1020867707079
Issue Date:
DOI: https://doi.org/10.1023/A:1020867707079